价格

chronic kidney disease therapeutic

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN
EP 4397675 A3申请人: BRISTOL MYERS SQUIBB CO优先权: 2012
CN
EP
US
WO
24 件公开
FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES
EP 3988170 A1申请人: NOVARTIS AG优先权: 2014
CN
EP
US
WO
13 件公开
Methods for treating and diagnosing disease
CN 105148269 A申请人: FIBROSTATIN SRL优先权: 2011
CN
EP
US
WO
6 件公开
ATRASENTAN MANDELATE SALTS FOR THE TREATMENT OF KIDNEY DISEASES
EP 3239148 A1申请人: ABBVIE INC优先权: 2013
CN
EP
US
6 件公开
MACROCYCLIC COMPOUND AND USE THEREOF
EP 3890738 A4申请人: SCOHIA PHARMA INC优先权: 2018
CN
EP
US
WO
5 件公开
A COMPOSITION COMPRISING LACTOBACILLUS STRAINS FOR TREATING OR PREVENTING CONDITIONS OF ELEVATED SERUM URATE
EP 4185309 C0申请人: BEO THERAPEUTICS优先权: 2020
CN
EP
US
WO
4 件公开
THERAPEUTIC FUSION PROTEINS
US 2023265160 A1申请人: NOVARTIS AG优先权: 2019
US
WO
4 件公开
Compounds as rearranged during transfection (RET) inhibitors
- US 8937071 B2
  申请人: GLAXOSMITHKLINE IP DEV LTD优先权: 2013
  US
  4 件公开
- US 9879021 B2
  申请人: GLAXOSMITHKLINE IP DEV LTD优先权: 2014
  US
  2 件公开
N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamides and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamides and their therapeutic use
US 9624167 B2申请人: PIMCO 2664 LTD优先权: 2013
US
4 件公开
Pyridone derivatives as rearranged during transfection (RET) kinase inhibitors
US 9918974 B2申请人: GLAXOSMITHKLINE IP DEV LTD优先权: 2014
US
4 件公开

药物

chronic kidney disease therapeutic

专利

Compounds as rearranged during transfection (RET) inhibitors